ATOMWISE
DEAD

Serial Number

90731554

Owner

Atomwise Inc.

Attorney

Carla B. Oakley

Filing Date

May 24, 2021

Add to watchlist:

No watchlists yet
View on USPTO

ATOMWISE Trademark

Serial Number: 90731554

ATOMWISE is a trademark filed by Atomwise Inc. on May 24, 2021. The trademark is classified under Class 5 (Pharmaceuticals). The application is currently no longer active.

Owner Contact Info

Atomwise Inc. (11 trademarks)

717 Market Street, 8th Floor
San Francisco, CA 94103

Entity Type: 03

Trademark Details

Filing Date

May 24, 2021

Registration Date

Not Registered

Published for Opposition

September 20, 2022

Goods & Services

pharmaceuticals, namely, anti-infectives; anti-inflammatories; antibacterial pharmaceuticals; antibiotics; antifungal preparations; antivirals; cardiovascular pharmaceuticals; dermatological pharmaceutical products; inhaled pharmaceutical preparations for the prevention and treatment of respiratory diseases and disorders; pharmaceutical preparations acting on the central nervous system; pharmaceutical preparations and substances for the prevention and treatment of gastro-intestinal diseases; pharmaceutical preparations for the prevention and treatment of diseases and disorders of the autoimmune system, the metabolic system, the endocrine system, the musculo-skeletal system and the genitourinary system; pharmaceutical preparations for use in hematology and in tissue and organ transplantation; pharmaceutical preparations for the prevention and treatment of eye diseases and conditions; pharmaceutical preparations for the prevention and treatment of heart rhythm disorders; pharmaceutical preparations for the prevention and treatment of immune system related diseases and disorders; pharmaceutical preparations for the prevention and treatment of kidney diseases; pharmaceutical preparations for the prevention and treatment of diabetes; pharmaceutical preparations for the prevention and treatment of hypertension; pharmaceutical preparations for the prevention and treatment of skin disorders; pharmaceutical preparations for use in dermatology; pharmaceutical preparations for use in urology; pharmaceutical products for ophthalmological use; pharmaceutical products for the prevention and treatment of cancer and tumors; pharmaceutical preparations for the prevention and treatment of allergies; pharmaceutical products for the prevention and treatment of bone diseases; pharmaceutical products for the prevention and treatment of respiratory diseases and asthma; pharmaceuticals for the treatment of rare diseases, vascular diseases and conditions, neurologic diseases and conditions, rheumatology conditions and diseases, and psychiatric conditions and diseases; chemical preparations and biological preparations for the treatment of diseases and disorders; herbicides, insecticides and pesticides

Filing History

ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
Dec 22, 2025 MAB6
ABANDONMENT - NO USE STATEMENT FILED
Dec 22, 2025 ABN6
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
May 2, 2025 EXRA
SOU EXTENSION 5 GRANTED
May 2, 2025 EX5G
SOU EXTENSION 5 FILED
May 1, 2025 EXT5
SOU TEAS EXTENSION RECEIVED
May 1, 2025 EEXT
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Nov 26, 2024 EXRA
SOU EXTENSION 4 GRANTED
Nov 26, 2024 EX4G
CASE ASSIGNED TO INTENT TO USE PARALEGAL
Nov 26, 2024 AITU
SOU EXTENSION 4 FILED
Nov 7, 2024 EXT4
SOU TEAS EXTENSION RECEIVED
Nov 7, 2024 EEXT
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
May 7, 2024 EXRA
SOU EXTENSION 3 GRANTED
May 6, 2024 EX3G
SOU EXTENSION 3 FILED
May 6, 2024 EXT3
SOU TEAS EXTENSION RECEIVED
May 6, 2024 EEXT
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Nov 8, 2023 EXRA
SOU EXTENSION 2 GRANTED
Nov 6, 2023 EX2G
SOU EXTENSION 2 FILED
Nov 6, 2023 EXT2
SOU TEAS EXTENSION RECEIVED
Nov 6, 2023 EEXT
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
May 4, 2023 EXRA
SOU EXTENSION 1 GRANTED
May 2, 2023 EX1G
SOU EXTENSION 1 FILED
May 2, 2023 EXT1
SOU TEAS EXTENSION RECEIVED
May 2, 2023 EEXT
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Nov 15, 2022 NOAM
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Sep 20, 2022 NPUB
PUBLISHED FOR OPPOSITION
Sep 20, 2022 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Aug 31, 2022 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Aug 17, 2022 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Aug 12, 2022 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Aug 11, 2022 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Aug 11, 2022 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Feb 11, 2022 GNRN
NON-FINAL ACTION E-MAILED
Feb 11, 2022 GNRT
NON-FINAL ACTION WRITTEN
Feb 11, 2022 CNRT
ASSIGNED TO EXAMINER
Feb 3, 2022 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Aug 24, 2021 NWOS
NEW APPLICATION ENTERED
May 27, 2021 NWAP